Since cancer cells shed the L1CAM ectodomain into circulation, the NeuGcAcGalβ1-4Galβ1-4 xeno-autoantigen potentially gives us a novel serum biomarker for early detection of melanoma. This evidence concerns the gene L1CAM and melanoma.